Three Palm nets CE Mark for mammo software

TriMed Staff | | Health Imaging | Screening
Three Palm Software has received a CE Mark for its WorkstationOne and CadOne mammography software, which clears the company to market the products within 30 countries of the European Union (EU).

The Los Gatos, Calif.-based company said its WorkstationOne is diagnostic breast imaging workstation software that obtains breast imaging screening or diagnosis exams from PACS or modalities, and displays and manipulates the images for radiologists to perform interpretation. 

CadOne is a mammography CAD server, offered to original equipment manufacturers for integration into their product suites, according to Three Palm. CadOne is used in mammography screening, in particular, with digital data source (e.g., FFDM or CR for mammography).

TriMed Staff

Related Content

Rising rates of interval breast cancers have experts calling for more risk-based screenings
Rates of breast cancer diagnosis, death expected to climb in coming decades
AI quantifies breast arterial calcifications on mammograms
AI 'not safe' to be implemented as a solo reader for breast cancer screening exams
American College of Radiology announces significant expansion of Lung Cancer Screening Registry
AI beats standard regression models at predicting lung cancer risk

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.